Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. haemodialysis
Show results for
Products

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Haemodialysis Articles & Analysis

13 articles found

Diabetic Foot Ulcer - Case Study

Diabetic Foot Ulcer - Case Study

Healing rate: 25.3 mm2/day. Healing time: 33 days. Wound size: 38 × 22 × 8 mm. Age of wound when treatment started: > 1 year. Subject: 52/male. Insulin dependent diabetic, peripheral neuropathy, hypertension, renal failure on hemodialysis; history of chronic foot ...

ByETS Wound Care


Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection

Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection

Background: Synthetic expanded polytetrafluorethylene (ePTFE) grafts are routinely used for vascular repair and reconstruction but prone to sustained bacterial infections. Investigational bioengineered human acellular vessels (HAVs) have shown clinical success and may confer lower susceptibility to infection. Here we directly compared the susceptibility of ePTFE grafts and HAV to bacterial ...

ByHumacyte, Inc.


Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care

Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care

ABSTRACT: The incidence of wartime vascular injury has increased and is a leading cause of mortality and morbidity. While ligation remains an option, current resuscitation and damage control techniques have resulted in vascular repair being pursued in more than half of wartime injuries. Options for vascular reconstruction are currently limited to autologous vein or synthetic conduits, choices ...

ByHumacyte, Inc.


An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

Abstract : Intimal hyperplasia is one of the prominent failure mechanisms for arteriovenous fistulas and arteriovenous access grafts. Human tissue-engineered vascular grafts (TEVGs) were implanted as arteriovenous grafts in a novel baboon model. Ultrasound was used to monitor flow rates and vascular diameters throughout the study. Intimal hyperplasia in the outflow vein of TEVGs was assessed at ...

ByHumacyte, Inc.


Learning to Use Heparin, a History

Learning to Use Heparin, a History

Discovery In the late 19th century, researchers attempted to produce a drug with a hemostatic effect by injecting a peptone and inducing the release of an anticoagulant. The water-soluble substance isolated from the liver was heparin, but no one knew it at the time. What unfolded over the next four decades would change the trajectory of anticoagulation treatment. By 1915, the most prominent ...

ByCoaguSense Inc.


Calcium Alginate Wound Dressings - Still Relevant Forty Years On!

Calcium Alginate Wound Dressings - Still Relevant Forty Years On!

SFM has been producing alginate products since the early 1980’s and still to this day alginates are an important product for our business. Alginate dressings are classed as ‘advanced wound care’, a label that up until now I have strongly disagreed with. How can a relatively simple dressing be thought of as ‘advanced’ in the current market? With newer ...

BySpeciality Fibres and Materials Ltd. (SFM)


Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. ...

ByHumacyte, Inc.


Facing Treatment of Kidney Disease with Hearing Disabilities

Facing Treatment of Kidney Disease with Hearing Disabilities

Around 37 million people in the United States and around 700 million people worldwide have chronic kidney disease which require patients to utilize dialysis centers. These dialysis clinics provide lifesaving treatments to the patients that need them. While having any medical procedure performed, communication between the healthcare provider and the patient is vital to ...

BySafe’N’Clear, Inc.


Early Experience with a Novel Hemodialysis System used for PIRRT Demonstrates Clinical Management at Lower Cost than CRRT and IHD - Case Study

Early Experience with a Novel Hemodialysis System used for PIRRT Demonstrates Clinical Management at Lower Cost than CRRT and IHD - Case Study

The need for providing dialysis to patients in the ICU has increased overtime. Delivery of this care is challenging to health care systems (HCS) both in costs and ...

ByOutset Medical


Nanjing Southern New Town Medical Center - Case Study

Nanjing Southern New Town Medical Center - Case Study

Opened in December 2018. As an important livelihood project, the Southern New Town Medical Center in the central area of the Southern New Town of Nanjing. 2.9 billion RMB has been invested to build the hospital. Large-scale comprehensive hospital, which integrates medical treatment, teaching, scientific research, rehabilitation, health care and first aid, and can accommodate 1500 beds. ...

ByGenano Industrial Air Purification Solutions - Genano Ltd.


Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Keywords Vascular access · Hemodialysis · Healthcare costs · Health economics · Arteriovenous fistula · Arteriovenous graft Abstract Introduction: Hemodialysis (HD) in end-stage renal disease (ESRD) patients requires vascular access (VA) through an arteriovenous fistula (AVF), a prosthetic arteriovenous graft (AVG), or a central venous catheter. While AVF or ...

ByHumacyte, Inc.


Link between Glyphosate and Kidney Disease

Link between Glyphosate and Kidney Disease

And now to a story that is never far from the headlines. If is about an EPA – Registered herbicide that has been linked to kidney disease. This story demonstrates the extent that entities will go to protext their commercial interests. The story comes from the organisation Beyond Pesticides. (Beyond Pesticides, February 6, 2019) The American Association for the Advancement of Science (AAAS) ...

ByAustralian Institute of Ecological Agriculture (AIEA)


Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Background: Arteriovenous fistulae are the currently recommended gold standard vascular access modality for haemodialysis because of their prolonged patency, improved durability, and low risk of infection for those that mature. ...

ByHumacyte, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT